News
CI Financial Obtains Shareholder Approval for Plan of Arrangement with Mubadala Capital
CI Financial Corp. (“CI” or the “Corporation”) (TSX:CIX) announced that at the special meeting of shareholders held earlier today, an overwhelming majority of CI shareholders voted in favour of the
CI Global Asset Management Announces February 2025 Distributions for the CI ETFs
CI Global Asset Management (“CI GAM”) announces the following regular cash distributions for the month ending February 28, 2025 in respect of the CI ETFs. In all cases, the distribution will be
Sensorion Announces its Participation in the Association for Research in Otolaryngology ARO 48th Annual Midwinter Meeting
Regulatory News:
Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent loss
DF company Vagabund Brauerei takes over the ‘OBC’ cider brand
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
TEAM's bid in the tender process for the UEFA club competitions for the 2027 - 2033 seasons remains unconsidered
Westwater Resources Successfully Commissions Kellyton Qualification Line
Westwater Resources, Inc. (NYSE: American: WWR), an energy technology and battery-grade natural graphite company (“Westwater” or the “Company”), announced today that it successfully commissioned
Custodian Property Income REIT plc: Block Listing interim review
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
CI Global Asset Management Funds Recognized for Investment Excellence
CI Global Asset Management (“CI GAM”) announces it has received 34 FundGrade A+® Awards for 2024. The awards recognize the “best of the best” in Canadian investment funds and CI GAM’s winners
Molten Ventures Plc: TR-1 Notification of Major Holdings
Westwater Resources Supports ITC Preliminary Determination on Chinese Graphite
Westwater Resources, Inc. (NYSE American: WWR), an energy technology and battery-grade natural graphite company (“Westwater” or the “Company”), supports the preliminary determination of the U.S
Vistagen to Report Fiscal Year 2025 Third Quarter Results and Host Corporate Update Conference Call on February 13, 2025
Vistagen (Nasdaq: VTGN), a clinical-stage biopharmaceutical company pioneering neuroscience with nose-to-brain neurocircuitry to develop and commercialize a new class of intranasal product
Form 8.3 - The Vanguard Group, Inc.: TI Fluid Systems plc
Form 8.3 - The Vanguard Group, Inc.: PRS REIT plc, The